Clinical Trial Update: Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating an anti-Toxoplasma gondii add-on therapy in Toxoplasma seropositive individuals with schizophrenia or major depressive disorder has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Schizophrenia

Snippet

Sponsor: Zentrum für Integrative Psychiatrie | Conditions: Schizophrenia, Major Depression | Phase 3 | Status: COMPLETED